Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.

<h4>Background</h4>Strongyloides stercoralis is not endemic in Aotearoa New Zealand (AoNZ). However, approximately one third of Auckland residents are born in endemic countries. This study aimed to describe the epidemiology and management of strongyloidiasis in Auckland, with a focus on...

Full description

Bibliographic Details
Main Authors: Tim Cutfield, Soana Karuna Motuhifonua, Matthew Blakiston, Hasan Bhally, Eamon Duffy, Rebekah Lane, Erik Otte, Terri Swager, Amanda Maree Taylor, Veronica Playle
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-03-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0012045&type=printable
_version_ 1797209629861609472
author Tim Cutfield
Soana Karuna Motuhifonua
Matthew Blakiston
Hasan Bhally
Eamon Duffy
Rebekah Lane
Erik Otte
Terri Swager
Amanda Maree Taylor
Veronica Playle
author_facet Tim Cutfield
Soana Karuna Motuhifonua
Matthew Blakiston
Hasan Bhally
Eamon Duffy
Rebekah Lane
Erik Otte
Terri Swager
Amanda Maree Taylor
Veronica Playle
author_sort Tim Cutfield
collection DOAJ
description <h4>Background</h4>Strongyloides stercoralis is not endemic in Aotearoa New Zealand (AoNZ). However, approximately one third of Auckland residents are born in endemic countries. This study aimed to describe the epidemiology and management of strongyloidiasis in Auckland, with a focus on migrants from Pacific Island Countries and Territories.<h4>Methods</h4>This study retrospectively reviewed clinical, laboratory and pharmacy records data for all people diagnosed with strongyloidiasis in the Auckland region between July 2012 and June 2022. People with negative Strongyloides serology were included to estimate seropositivity rate by country of birth.<h4>Findings</h4>Over ten years, 691 people were diagnosed with strongyloidiasis. Most diagnoses were made by serology alone (622, 90%). The median age was 63 years (range 15-92), 500 (72%) were male, and the majority were born in Polynesia (350, 51%), Fiji (130, 19%) or were of Pasifika ethnicity (an additional 7%). Twelve participants (1.7%) had severe strongyloidiasis at diagnosis. The total proportion treated with ivermectin was only 70% (484/691), with no differences between immunocompromised and immunocompetent participants, nor by ethnicity. The outcome of treatment (based on a combination of serology and/or eosinophilia and/or stool microscopy) could only be determined in 50% of the treated cohort. One participant failed treatment with ivermectin, experiencing recurrent strongyloidiasis, and another participant died in association with severe strongyloidiasis. The rate of 'positive' Strongyloides serology was highest among participants born in Samoa (48%), Fiji (39%), and Southeast Asian countries (34%).<h4>Interpretation</h4>Strongyloidiasis was common and under-treated in Auckland during the study period. Clinicians should have a low threshold for considering strongyloidiasis in migrants from endemic countries, including Polynesia and Fiji.
first_indexed 2024-04-24T09:57:45Z
format Article
id doaj.art-8594b1467f364982b041ca6568550ec3
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-04-24T09:57:45Z
publishDate 2024-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-8594b1467f364982b041ca6568550ec32024-04-14T05:32:09ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352024-03-01183e001204510.1371/journal.pntd.0012045Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.Tim CutfieldSoana Karuna MotuhifonuaMatthew BlakistonHasan BhallyEamon DuffyRebekah LaneErik OtteTerri SwagerAmanda Maree TaylorVeronica Playle<h4>Background</h4>Strongyloides stercoralis is not endemic in Aotearoa New Zealand (AoNZ). However, approximately one third of Auckland residents are born in endemic countries. This study aimed to describe the epidemiology and management of strongyloidiasis in Auckland, with a focus on migrants from Pacific Island Countries and Territories.<h4>Methods</h4>This study retrospectively reviewed clinical, laboratory and pharmacy records data for all people diagnosed with strongyloidiasis in the Auckland region between July 2012 and June 2022. People with negative Strongyloides serology were included to estimate seropositivity rate by country of birth.<h4>Findings</h4>Over ten years, 691 people were diagnosed with strongyloidiasis. Most diagnoses were made by serology alone (622, 90%). The median age was 63 years (range 15-92), 500 (72%) were male, and the majority were born in Polynesia (350, 51%), Fiji (130, 19%) or were of Pasifika ethnicity (an additional 7%). Twelve participants (1.7%) had severe strongyloidiasis at diagnosis. The total proportion treated with ivermectin was only 70% (484/691), with no differences between immunocompromised and immunocompetent participants, nor by ethnicity. The outcome of treatment (based on a combination of serology and/or eosinophilia and/or stool microscopy) could only be determined in 50% of the treated cohort. One participant failed treatment with ivermectin, experiencing recurrent strongyloidiasis, and another participant died in association with severe strongyloidiasis. The rate of 'positive' Strongyloides serology was highest among participants born in Samoa (48%), Fiji (39%), and Southeast Asian countries (34%).<h4>Interpretation</h4>Strongyloidiasis was common and under-treated in Auckland during the study period. Clinicians should have a low threshold for considering strongyloidiasis in migrants from endemic countries, including Polynesia and Fiji.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0012045&type=printable
spellingShingle Tim Cutfield
Soana Karuna Motuhifonua
Matthew Blakiston
Hasan Bhally
Eamon Duffy
Rebekah Lane
Erik Otte
Terri Swager
Amanda Maree Taylor
Veronica Playle
Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.
PLoS Neglected Tropical Diseases
title Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.
title_full Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.
title_fullStr Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.
title_full_unstemmed Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.
title_short Strongyloidiasis in Auckland: A ten-year retrospective study of diagnosis, treatment and outcomes of a predominantly Polynesian and Fijian migrant cohort.
title_sort strongyloidiasis in auckland a ten year retrospective study of diagnosis treatment and outcomes of a predominantly polynesian and fijian migrant cohort
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0012045&type=printable
work_keys_str_mv AT timcutfield strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT soanakarunamotuhifonua strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT matthewblakiston strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT hasanbhally strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT eamonduffy strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT rebekahlane strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT erikotte strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT terriswager strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT amandamareetaylor strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort
AT veronicaplayle strongyloidiasisinaucklandatenyearretrospectivestudyofdiagnosistreatmentandoutcomesofapredominantlypolynesianandfijianmigrantcohort